Jul 12 2010
Lifeline Biotechnologies, Inc. (Pink Sheets: LLBO) announced today that it has retained legal counsel to resolve the trading issue with Depository Trust Corporation (DTC) in order to re-establish clearing services.
“We have no association or knowledge of LEEB, its counterparts, representatives or their activities concerning the trading of Lifeline's shares.”
Jim Holmes, Lifeline's CEO, said, "We have retained special counsel to assist us in re-establishing Depository Trust's services to our Company. The law firm we have retained has been successful in re-establishing DTC's services to other public companies who, the SEC alleges, were a part of the LEEB Brokerage Services' questionable stock transactions, and is currently working with DTC's outside legal counsel to remove the 'chill' that was placed on our stock in May."
Holmes reaffirmed, "We have no association or knowledge of LEEB, its counterparts, representatives or their activities concerning the trading of Lifeline's shares."
Source:
Lifeline Biotechnologies, Inc.